Field anesthesia of wild Arctic fox (Alopex lagopus) cubs in the Swedish Lapland using medetomidine-ketamine-atipamezole

Journal of Zoo and Wildlife Medicine

Volumn 31, Issue 2, 2000, Pages 244-246

  Aguirre, A Alonso ^a,c   Principe, B ^a   Tannerfeldt, Magnus ^b   Angerbjörn, Anders ^b   Mörner, Torsten ^a  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Alopex lagopus; Arctic fox; Atipamezole; Ketamine; Medetomidine; Pulse oximetry; Sweden

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ATIPAMEZOLE; HYPNOTIC SEDATIVE AGENT; IMIDAZOLE DERIVATIVE; KETAMINE; MEDETOMIDINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BODY TEMPERATURE; ENVIRONMENTAL PROTECTION; FEMALE; FOX; HEART RATE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; OXIMETRY; PHYSIOLOGY; STANDARD; SWEDEN;

ADRENERGIC ALPHA-AGONISTS; ANESTHETICS, COMBINED; ANESTHETICS, DISSOCIATIVE; ANIMALS; BODY TEMPERATURE; CONSERVATION OF NATURAL RESOURCES; FEMALE; FOXES; HEART RATE; HYPNOTICS AND SEDATIVES; IMIDAZOLES; INJECTIONS, INTRAMUSCULAR; KETAMINE; MALE; MEDETOMIDINE; OXIMETRY; SWEDEN;

EID: 0034207685     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/1042-7260(2000)031[0244:FAOWAF]2.0.CO;2     Document Type: Article

References (19)

1. Aguirre, A. A., M. Tannerfeldt, A. Angerbjörn, and T. Mörner. 2000. Health evaluation of endangered arctic fox (Alopex lagopus) cubs in Sweden. J. Zoo Wildl. Med. 31: 36-40.
2. Angerbjörn, A., M. Tannerfeldt, A. Bjärvall, M. Ericson, J. From, and E. Norén. 1995. Dynamics of the arctic fox population in Sweden. Ann. Zool. Fenn. 32: 55-68.
3. Berthier, J.-L., M.-C. Bomsel, and S. Gerbet. 1995. Anesthesie des animaux sauvages; association medetomidine-ketamine et atipamezole. Le Point Vet. 27: 67-72.
4. Grandy, J. L., and C. I. Dunlop. 1991. Anesthesia of pups and kittens. J. Am. Vet. Med. Assoc. 198: 1244-1249.
5. Hellebrekers, L. J. 1990. Non-opiate anaesthesia in dogs, induced by intramuscular injection. Tijdschr. Diergeneeskd. 115: 661-668.
6. Heuschele, W. P. 1969. Experiences with promazine in captive wild animals. Biochem. Rev. 29: 3-4.
7. Holz, P. H., R. M. Holz, and J. E. F. Barnett. 1994. Effects of atropine on medetomidine/ketamine immobilization in the gray wolf (Canis lupus). J. Zoo Wildl. Med. 25: 209-213.
8. Jalanka, H. H. 1990. The use of medetomidine: medetomidine-ketamine induced immobilization in blue foxes (Alopex lagopus) and its reversal by atipamezole. Acta Vet. Scand. 31: 63-71.
9. Jalanka, H. H., and B. O. Roeken. 1990. The use of medetomidine, medetomidine-ketamine combinations, and atipamezole in non-domestic mammals: a review. J. Zoo Wildl. Med. 21: 259-282.
10. Kreeger, T. J. 1996. Handbook of Wildlife Chemical Immobilization. International Wildlife Veterinary Services, Laramie, Wyoming.
11. Kreeger, T. J., M. Callahan, and M. Beckel. 1996. Use of medetomidine for chemical restraint of captive gray wolves (Canis lupus). J. Zoo Wildl. Med. 27: 507-512.
12. Paddleford, R. R. 1988. Manual of Small Animal Anesthesia. Churchill Livingstone, New York, New York. Pp. 253-259.
13. Reens, N. 1993. Medetomidine as a premedicant for ketamine or propofol anaesthesia in dogs. Tijdschr. Diergeneeskd. 115(Suppl. 1): 661-668.
14. Seal, U. S., A. W. Erickson, and J. G. Mayo. 1970. Drug immobilization of the Carnivora. Int. Zoo Yearb. 10: 157-170.
15. Short, C. E. 1991. Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine. Vet. Rec. 129: 310-313.
16. Tannerfeldt, M., A. Angerbjörn, and B. Arvidson. 1994. The effect of summer feeding on juvenile arctic fox survival; a field experiment. Ecography 17: 88-96.
17. Thurmon, J. C., W. J. Tranquilli, and G. J. Benson. 1996. Lumb & Jone's Veterinary Anesthesia, 3rd ed. Williams & Wilkins, Baltimore, Maryland. Pp. 844-848.
18. Vaha-Vahe, A. T. 1990. Clinical effectiveness of atipamezole as a medetomidine antagonist in the dog. J. Vet. Pharmacol. Ther. 13: 198-205.
19. 2 adrenoreceptor agonist. Eur. J. Pharmacol. 150: 9-14.